News
StockStory.org on MSN7d
5 Must-Read Analyst Questions From Fortune Brands’s Q1 Earnings CallFortune Brands’ first quarter results were met with a notably negative market reaction, as the company reported ...
Shares of Fortune Brands Innovations Inc. FBIN slid 1.58% to $53.45 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.83% to ...
Fortune Brands Innovation Inc. (Nasdaq: FBIN), Moen’s parent company, in January announced a corporate restructuring effort that included plans to downsize its footprint and relocate and consolidate ...
Hosted on MSN2mon
Fortune Brands Earnings: What To Look For From FBIN - MSNFortune Brands missed analysts’ revenue expectations by 3.5% last quarter, reporting revenues of $1.10 billion, down 4.9% year on year. It was a disappointing quarter for the company, with full ...
Review the current Fortune Brands Innovations Inc (FBIN:XNYS) dividend yield and history to decide if FBIN is the best investment for you.
After years of speculation, Fortune Brands Inc. has decided to break up the widely diverse company, adding to the roster of Chicago-area companies that will shrink considerably. The Deerfield-based… ...
Home and security products company Fortune Brands (NYSE:FBIN) in Q4 CY2024, with sales falling 4.9% year on year to $1.10 billion. Its GAAP profit of $0.84 per share was 20.1% below analysts ...
Hosted on MSN11mon
Fortune Brands Innovations declares $0.24 dividend - MSNFortune Brands Innovations (NYSE:FBIN) declares $0.24/share quarterly dividend, in line with previous. Forward yield 1.34% Payable Sept. 11; for shareholders of record Aug. 23; ex-div Aug. 23.
Fortune Brands (FO), maker of Jim Beam whisky, plans to split into three separate units. Fortune Brands will continue to focus on its distilled spirits business, the company said in a statement.
Fortune Brands recently announced it will consolidate its U.S offices into one headquarters, taking over two of three office buildings previously owned by Horizon Therapeutics, then Amgen Inc., at … ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results